已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Role of CpG oligodeoxynucleotide in angiogenesis

血管生成 CpG寡核苷酸 巨噬细胞 细胞生物学 免疫学 趋化因子 脐静脉 细胞迁移 化学 癌症研究 生物 免疫系统 体外 DNA甲基化 生物化学 基因 基因表达
作者
Lei Liu,Jia-Hui Wu,Jian Liu,Andrew D. Dick
出处
期刊:The Lancet [Elsevier]
被引量:1
标识
DOI:10.1016/s0140-6736(16)00452-9
摘要

Abstract Background Angiogenesis involves multiple cell types, including close association with immune cells and vascular growth factors. We have previously shown that the toll-like receptor 9 (TLR9) agonist CpG oligodeoxynucleotide (ODN) inhibits corneal angiogenesis. We aimed to investigate how CpG ODNs regulate vascular endothelial cells, pericytes, and macrophages and whether macrophages are required for the anti-angiogenic process. Methods Regulation of angiogenesis by CpG ODN was determined in various in-vivo models (corneal neovascularisation and laser-induced choroidal neovascularisation). Human umbilical vein endothelial cells (HUVEC) were stimulated with CpG ODN to determine tube formation and cell migration. Migration of either pericytes or bone-marrow-derived macrophages was determined by co-culture with HUVEC medium conditioned with CpG ODN. Before CpG ODN treatment, macrophages were depleted by clodronate, or macrophage subpopulations were selectively depleted with antibodies to chemokine receptor type 2 (anti-CCR2). Findings CpG ODN suppressed suture-induced corneal neovascularisation and laser-induced choroidal neovascularisation. Conditioned HUVEC medium enhanced macrophage migration but limited pericyte mobilisation. After macrophage depletion by clodronate or anti-CCR2, a reduction in suture-induced corneal neovascularisation was noted; however, treatment with CpG ODN did not augment this response in the absence of macrophages. CpG ODN promoted macrophage M1 polarisation, and macrophages lacking CCR2 attenuated HUVEC tube formation. Interpretation We have shown that the regulation of angiogenesis by CpG ODN is ubiquitous through a variety of pathways. CpG ODN maintains endothelial cells in stalk status and reduces pericyte migration to support vessel formation. Macrophage depletion subverts any additive anti-angiogenic regulation of CpG ODN treatment. CpG ODN promotes macrophage mobilisation with mainly M1 phenotype of which probably the CCR2 population regulates endothelial cells as a result of anti-angiogenesis. Funding Rosetrees Trust, Academy of Medical Sciences, National Institute for Health Research, National Eye Research Centre, Fight for Sight PhD studentship.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
黑子哲也发布了新的文献求助20
1秒前
李爱国应助liuzengzhang666采纳,获得10
1秒前
2秒前
Ji完成签到,获得积分10
2秒前
大个应助高山七石采纳,获得10
6秒前
7秒前
失眠的广山完成签到 ,获得积分10
8秒前
zency发布了新的文献求助10
8秒前
wentong完成签到,获得积分10
8秒前
12秒前
Linson完成签到,获得积分10
13秒前
数值分析完成签到 ,获得积分10
15秒前
HughWang完成签到,获得积分10
15秒前
李健应助iwjlkdjalkjc采纳,获得10
16秒前
lvsehx发布了新的文献求助10
17秒前
zzzzzttt完成签到 ,获得积分10
18秒前
123完成签到 ,获得积分10
19秒前
叫我益达完成签到,获得积分10
19秒前
20秒前
keyandog发布了新的文献求助30
21秒前
23秒前
wilson完成签到,获得积分10
24秒前
忧伤的冰薇完成签到 ,获得积分10
27秒前
Jiro完成签到,获得积分10
27秒前
滴滴哒哒完成签到 ,获得积分10
28秒前
iwjlkdjalkjc发布了新的文献求助10
29秒前
30秒前
破晓完成签到 ,获得积分10
34秒前
白白白完成签到 ,获得积分10
35秒前
英俊的铭应助wilson采纳,获得10
35秒前
嘻yyy完成签到 ,获得积分10
43秒前
pzh完成签到 ,获得积分10
46秒前
隐形曼青应助sptyzl采纳,获得10
48秒前
黑子哲也完成签到,获得积分20
50秒前
生动的大地完成签到,获得积分10
51秒前
keyandog完成签到,获得积分10
57秒前
59秒前
MMMMMeng完成签到,获得积分10
59秒前
糖伯虎完成签到 ,获得积分10
1分钟前
wilson发布了新的文献求助10
1分钟前
高分求助中
Lire en communiste 1000
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Becoming: An Introduction to Jung's Concept of Individuation 600
肝病学名词 500
Evolution 3rd edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3171355
求助须知:如何正确求助?哪些是违规求助? 2822342
关于积分的说明 7938795
捐赠科研通 2482815
什么是DOI,文献DOI怎么找? 1322807
科研通“疑难数据库(出版商)”最低求助积分说明 633742
版权声明 602627